GlassScriptPhysician profile
Robert Richard Winter
NPI 1831302736
$734,589.23
in general payments reported to CMS, 2019-2025
7 companies · $123K in 2025
The $123K reported for 2025 was more than what 99% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109K · 2020: $75K · 2021: $92K · 2022: $110K · 2023: $110K · 2024: $115K · 2025: $123K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $220K · Royalty Or License: $110K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $944 · Travel and Lodging: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $219,999.84 |
| Royalty Or License | $109,999.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,112.94 |
| Food and Beverage | $943.66 |
| Travel and Lodging | $706.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peter Brasseler Holdings, LLC | $731,241.17 | 2019-2025 | |
| Kuraray America INC. | $1,433.67 | 2024 | |
| Ivoclar Vivadent, INC. | $940.87 | 2020-2024 | |
| Dmg America LLC | $748.30 | 2019 | |
| Hu-Friedy Mfg. Co., LLC | $161.85 | 2019 | |
| Biohorizons Implant Systems INC. | $39.32 | 2019 | |
| Kulzer, LLC | $24.05 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.